Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation
暂无分享,去创建一个
[1] Osama Mawlawi,et al. Multimodality imaging: an update on PET/CT technology , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[2] J. Stoker,et al. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.
[3] K. Haustermans,et al. Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study , 2011, Annals of Surgical Oncology.
[4] Myeong-Jin Kim,et al. Abstracts of selected papers from the current literature , 2003, Abdominal Imaging.
[5] Jürgen Griebel,et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.
[6] Philippe Lambin,et al. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. , 2010, International journal of radiation oncology, biology, physics.
[7] Jeong Min Lee,et al. Dynamic contrast‐enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer , 2014, Journal of magnetic resonance imaging : JMRI.
[8] Christian Kremser,et al. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. , 2005, European journal of radiology.
[9] Xiaoguang Sun,et al. 18F‐FDG‐PET evaluation of treatment response to neo‐adjuvant therapy in patients with locally advanced rectal cancer: A meta‐analysis , 2012, International journal of cancer.
[10] Myeong-Jin Kim,et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer , 2012, European Radiology.
[11] Kenya Murase,et al. Efficient method for calculating kinetic parameters using T1‐weighted dynamic contrast‐enhanced magnetic resonance imaging , 2004, Magnetic resonance in medicine.
[12] J. Petiot,et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.
[13] A. Padhani,et al. Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer , 2001, The British journal of surgery.
[14] Geerard L Beets,et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] T. Junginger,et al. Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer , 2008, Annals of Surgical Oncology.
[16] A. Fichera,et al. Modern Rectal Cancer Multidisciplinary Treatment: The Role of Radiation and Surgery , 2013, Annals of Surgical Oncology.
[17] G. Beets,et al. MRI After Chemoradiotherapy of Rectal Cancer: A Useful Tool to Select Patients for Local Excision , 2010, Diseases of the colon and rectum.
[18] J. Gama-Rodrigues,et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.
[19] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[20] J. Jass,et al. Reporting colorectal cancer. , 1987, Journal of clinical pathology.
[21] J P Logue,et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] A. Padhani,et al. Tumor response assessments with diffusion and perfusion MRI , 2012, Journal of magnetic resonance imaging : JMRI.
[23] Maaike R Moman,et al. Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. , 2012, International journal of radiation oncology, biology, physics.
[24] M. Philippens,et al. Diffusion-weighted MRI in locally advanced rectal cancer , 2013, Strahlentherapie und Onkologie.
[25] Karin Haustermans,et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. , 2012, International journal of radiation oncology, biology, physics.
[26] J. Borrás,et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[28] Philippe Lambin,et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. , 2005, International journal of radiation oncology, biology, physics.
[29] S. Nougaret,et al. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience , 2013, Journal of magnetic resonance imaging : JMRI.
[30] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[31] Uulke A. van der Heide,et al. Simultaneous multi-modality ROI delineation in clinical practice , 2009, Comput. Methods Programs Biomed..